Renal Ischemia-Reperfusion Injury: New Implications of Dendritic Cell-Endothelial Cell Interactions

Transplantation Proceedings

Volumn 38, Issue 3, 2006, Pages 670-673

  Schlichting, C L ^a   Schareck, W D ^a   Weis, M ^b  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALLOGRAFT; ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; DENDRITIC CELL; ENDOTHELIUM CELL; GRAFT REJECTION; HUMAN; HYPOXIA; IMMUNITY; IMMUNOGENICITY; IMMUNOMODULATION; INFLAMMATION; KIDNEY INJURY; KIDNEY ISCHEMIA; LEUKOCYTE; LYMPH VESSEL; LYMPHOID ORGAN; MODEL; PRIORITY JOURNAL; REPERFUSION INJURY; SMOOTH MUSCLE TONE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VASCULAR SMOOTH MUSCLE;

ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; ENDOTHELIUM, VASCULAR; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; RENAL CIRCULATION; REPERFUSION INJURY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33646493170     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.01.059     Document Type: Article

References (52)

1. Schlichting C.L., Schareck W.D., Nickel T., et al. Dendritic cells as pharmacological targets for the generation of regulatory immunosuppressive effectors. New implications for allo-transplantation. Curr Med Chem 12 (2005) 1921
2. Hariharan S., Johnson C.P., Bresnahan B.A., et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342 (2000) 605
3. Paul L.C. Chronic allograft nephropathy. an update. Kidney Int 56 (1999) 783
4. Shoskes D.A., and Halloran P.F. Delayed graft function in renal transplantation. etiology, management and long-term significance. J Urol 155 (1996) 1831
5. Newstead C.G. Assessment of risk of cancer after renal transplantation. Lancet 351 (1998) 610
6. Sayegh M.H., and Carpenter C.B. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med 351 (2004) 2761
7. Ojo A.O., Wolfe R.A., Held P.J., et al. Delayed graft function. risk factors and implications for renal allograft survival. Transplantation 63 (1997) 968
8. Salahudeen A.K., Haider N., and May W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 65 (2004) 713
9. Lindholm A., Ohlman S., Albrechtsen D., et al. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 56 (1993) 307
10. van Saase J.L., van der Woude F.J., Thorogood J., et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 59 (1995) 1280
11. Gjertson D.W. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation. 1996 UNOS update. Clin Transpl x (1996) 343
12. Sienko J., Wisniewska M., Ostrowski M., et al. Factors that impact on immediate graft function in patients after renal transplantation. Transplant Proc 35 (2003) 2153
13. Rainger G.E., Fisher A., Shearman C., et al. Adhesion of flowing neutrophils to cultured endothelial cells after hypoxia and reoxygenation in vitro. Am J Physiol 269 (1995) H1398
14. Weis M., Schlichting C.L., Engleman E.G., et al. Endothelial determinants of dendritic cell adhesion and migration. new implications for vascular diseases. Arterioscler Thromb Vasc Biol 22 (2002) 1817
15. Weis M., and Cooke J.P. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway. Arterioscler Thromb Vasc Biol 23 (2003) 567
16. Foegh M.L., and Ramwell P.W. Pharmacologic control of smooth muscle cells in allografts. Transpl Immunol 5 (1997) 267
17. Weis M., and von Scheidt W. Cardiac allograft vasculopathy. a review. Circulation 96 (1997) 2069
18. Kofler S., Nickel T., and Weis M. Role of cytokines in cardiovascular diseases. a focus on endothelial responses to inflammation. Clin Sci (Lond) 108 (2005) 205
19. Hansson G.K., Libby P., Schonbeck U., et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91 (2002) 281
20. Weis M., and von Scheidt W. Coronary artery disease in the transplanted heart. Annu Rev Med 51 (2000) 81
21. Nagorsen D., Marincola F.M., and Panelli M.C. Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays. Cytokine 25 (2004) 31
22. Saint-Vis B., Fugier-Vivier I., and Massacrier C. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 160 (1998) 1666
23. Flores J., DiBona D.R., Beck C.H., et al. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest 51 (1972) 118
24. Sutton T.A., Mang H.E., Campos S.B., et al. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 285 (2003) F191
25. Pomfy M., and Huska J. The state of the microcirculatory bed after total ischaemia of the brain. An experimental ultrastructural study. Funct Dev Morphol 2 (1992) 253
26. van der P.T., and van Deventer S.J. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 13 (1999) 413
27. Vollmar B., Glasz J., Leiderer R., et al. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145 (1994) 1421
28. Yang Y., and Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 101 (2000) 2144
29. Chan L., Chittinandana A., Shapiro J.I., et al. Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol 266 (1994) F135
30. Gellai M., Jugus M., Fletcher T., et al. Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat. J Clin Invest 93 (1994) 900
31. Kelly K.J., Tolkoff-Rubin N.E., Rubin R.H., et al. An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury. Am J Physiol 271 (1996) F1061
32. Ignarro L.J., Buga G.M., Wood K.S., et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84 (1987) 9265
33. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide. physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109
34. Rubanyi G.M., and Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250 (1986) H822
35. Land W., Schneeberger H., Schleibner S., et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 57 (1994) 211
36. Cooke J.P., and Dzau V.J. Nitric oxide synthase. role in the genesis of vascular disease. Annu Rev Med 48 (1997) 489
37. Bannerman D.D., and Goldblum S.E. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 284 (2003) L899
38. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11 (1993) 767
39. Brown K.A. Factors modifying the migration of lymphocytes across the blood-brain barrier. Int Immunopharmacol 1 (2001) 2043
40. Hickey M.J., Granger D.N., and Kubes P. Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions. studies in iNOS-deficient mice. Acta Physiol Scand 173 (2001) 119
41. Bahra P., Rainger G.E., Wautier J.L., et al. Each step during transendothelial migration of flowing neutrophils is regulated by the stimulatory concentration of tumour necrosis factor-alpha. Cell Adhes Commun 6 (1998) 491
42. Linas S.L., Shanley P.F., Whittenburg D., et al. Neutrophils accentuate ischemia-reperfusion injury in isolated perfused rat kidneys. Am J Physiol 255 (1988) F728
43. Brodsky S.V., Yamamoto T., Tada T., et al. Endothelial dysfunction in ischemic acute renal failure. rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282 (2002) F1140
44. Penfield J.G., Dawidson I.A., Ar'Rajab A., et al. Syngeneic renal transplantation increases the number of renal dendritic cells in the rat. Transpl Immunol 7 (1999) 197
45. Sonderbye L., Meehan S., Palsson R., et al. Immunohistochemical study of actin binding protein (p55) in the human kidney. Transplantation 65 (1998) 1004
46. Wakabayashi T., and Onoda H. Interdigitating reticulum cells in human renal grafts. Virchows Arch A Pathol Anat Histopathol 418 (1991) 105
47. Milton A.D., Spencer S.C., and Fabre J.W. The effects of cyclosporine on the induction of donor class I and class II MHC antigens in heart and kidney allografts in the rat. Transplantation 42 (1986) 337
48. Chen T., Guo J., Yang M., et al. Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 103 (2004) 413
49. Randolph G.J. Dendritic cell migration to lymph nodes. cytokines, chemokines, and lipid mediators. Semin Immunol 13 (2001) 267
50. Kellermann S.A., Hudak S., Oldham E.R., et al. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol 162 (1999) 3859
51. Schlichting C.L., Schareck W.D., and Weis M. Dendritic cell adhesion is enhanced on endothelial cells preexposed to calcineurin inhibitors. J Cardiovasc Pharmacol 46 (2005) 250
52. Randolph G.J., Beaulieu S., Lebecque S., et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282 (1998) 480